Abstract
BackgroundTIL therapy, a personalized cell therapy comprising T cells that have been expanded ex vivo, is a promising treatment approach for advanced solid tumors. Retention of tumor-specific T-cell clonotypes and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
